Warning letter
Ophthalmic International: warning letter of Feb 12, 1998
FDA warning letter UCM066281 · Los Angeles District Office
Key facts
| Reference number | UCM066281 |
|---|---|
| Company | Ophthalmic International |
| Subject | Premarket Approval Application [PMA] |
| Issue date | Feb 12, 1998 |
| Posted date | Feb 12, 1998 |
| Issuing office | Los Angeles District Office |
| Product type | Unknown |
| CFR sections cited | 812.20, 807.81(a)(3)(i), 812.7(a), 807.81(a), 812.20(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: